Outcome After Plate Osteosynthesis of Proximal Humerus Fractures Using Continous Passive Motioning Therapy

Sponsor
Technische Universität Dresden (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05952622
Collaborator
(none)
103
1
2
69
1.5

Study Details

Study Description

Brief Summary

Patients suffering from a proximal humerus fracture treated with plate osteosynthesis will receive either regular aftercare (physiotherapy) or aftercare assisted with continous passive motion (physiotherapy + CPM). Change in functional and patient-reported outcome (PROM) over time will be evaluated and compared.

Condition or Disease Intervention/Treatment Phase
  • Device: Continuous passive motion therapy
N/A

Detailed Description

The investigators will conduct a prospective, monocentric study focusing on the rehabilitation process after surgical treatment of proximal humerus fractures. Patients treated with plate osteosynthesis and eligible to participate will be randomly assigend to either a regular rehabilitation protocol (immobilization and physiotherapy) or a rehabilitation protocol with the additional use of a continous passive motion device (immobilization, physiotherapy and CPM).

After 6 and 12 weeks as well as 1 year in a follow-up examination functional (range of motion) and patient-reported outcome (Disabilities of Arm, Shoulder and Hand Score [DASH], Constant-Score, pain on visual analogue scale, subjective satisfaction) will be evaluated. Results will be compared towards possible differences and effect of CPM therapy. In addition demographic factors (age, sex, BMI, etc.) and complications will be analysed.

Study Design

Study Type:
Interventional
Actual Enrollment :
103 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patients are assigned to one of two rehabilitation protocols consisting of either A: initial immobilization followed by physiotherapy or B: initial immobilization followed by physiotherapy and additional continuous passive motion therapyPatients are assigned to one of two rehabilitation protocols consisting of either A: initial immobilization followed by physiotherapy or B: initial immobilization followed by physiotherapy and additional continuous passive motion therapy
Masking:
None (Open Label)
Masking Description:
Patients are randomly assigend, masking is not possible.
Primary Purpose:
Treatment
Official Title:
Comparison of Functional and Patient-reported Outcome Using Continuous Passive Motion in Rehabilitation After Plate Osteosynthesis of Proximal Humerus Fractures
Actual Study Start Date :
Apr 1, 2018
Actual Primary Completion Date :
Feb 28, 2022
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Standard rehabilitation protocol

Standard rehabilitation after surgical treatment consisting of initial immobilization followed by physiotherapy.

Active Comparator: Rehabilitation protocol with CPM

Additional treatment of patients with continuous passive motion after initial immobilization for 6 weeks.

Device: Continuous passive motion therapy
Patients will be supplied with a continuous passive motion device which will allow additional individual treatment of the affected shoulder for 6 weeks.

Outcome Measures

Primary Outcome Measures

  1. Change in Range of Motion (ROM) after 6 weeks, 12 weeks and 1 year [Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment]

    Objetive functional clinical result. Evaluation ot Motion of the shoulder in ° measured via goniometer. Physiological Abduction/Adduction: 180/0/40°, Anteversion/Retroversion 160/0/40°, external/internal rotation: 70/0/60°

  2. Change of Disabilities of Arm, Shoulder and Hand Score (DASH) after 6 weeks, 12 weeks and 1 year [Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment]

    Evaluation of the subjective function (patient reported outcome) using the DASH-Score, 0-100, best: 0, worst: 100

  3. Change of Constant-Score (CSS) after 6 weeks, 12 weeks and 1 year [Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment]

    Evaluation of the subjective function (patient reported outcome) using the Constant-Score, 0-100, best: 100, worst: 0

  4. Change of Pain on visual analogue scale (VAS) after 6 weeks, 12 weeks and 1 year [Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment]

    Evaluation of the subjective pain using a visual analogue scale, 0-10, best:0, worst: 10

  5. Change of Subjective satisfaction with surgical treatment (SSV) after 6 weeks, 12 weeks and 1 year [Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment]

    Evaluation of the subjective satisfaction using the subjective shoulder value, 0-100, best:100, worst: 0

Secondary Outcome Measures

  1. Influence of demographic factors upon rehabilitation process [Time of Follow-Up assesment, 6 and 12weeks as well as 1year after surgical treatment]

    Evaluation of the underlying demographic factors (gender, age, BMI) and whether these affect the functional and patient-reported outcome (univariate regressional analysis)

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • patients with proximal humeral fracture treated with plate osteosynthesis during the enrollment period

  • understanding of German language (written and oral)

  • written informed consent of the patient or the legal guardian

Exclusion Criteria:
  • patients not meeting the aforementioned criteria

  • patients with the need of / or an already existing endoprosthesis

  • patients with ipsilateral fracture of the distal radius

  • patients with cerebral damage (contusio or commotio cerebri)

  • patients with affection of the brachial plexus or nerve palsy

  • non-compliance

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Center of Orthopaedics and Traumatology, University Medicine Carl Gustav Carus Dresden, TU Dresden Dresden Saxonia Germany 01307

Sponsors and Collaborators

  • Technische Universität Dresden

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Technische Universität Dresden
ClinicalTrials.gov Identifier:
NCT05952622
Other Study ID Numbers:
  • CPM
First Posted:
Jul 19, 2023
Last Update Posted:
Jul 19, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Technische Universität Dresden
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 19, 2023